Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Therapy Complications”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Testing effectiveness (Phase 2)Study completedNCT04817774
What this trial is testing

Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients

Who this might be right for
Kidney Transplant RejectionEnd Stage Renal Disease
Sangamo Therapeutics 26
Early research (Phase 1)Looking for participantsNCT06215950
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

Who this might be right for
Ovarian CancerCervix CancerMetastatic Cancer+2 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Early research (Phase 1)Looking for participantsNCT04897321
What this trial is testing

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Who this might be right for
Pediatric Solid TumorOsteosarcomaRhabdomyosarcoma+13 more
St. Jude Children's Research Hospital 48
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT03356795
What this trial is testing

Intervention of CAR-T Against Cervical Cancer

Who this might be right for
Cervical Cancer
Shenzhen Geno-Immune Medical Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT01218867
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer

Who this might be right for
Metastatic CancerMetastatic MelanomaRenal Cancer
National Cancer Institute (NCI) 24
Very early researchTemporarily pausedNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Testing effectiveness (Phase 2)Looking for participantsNCT05952804
What this trial is testing

IVIG for Infection Prevention After CAR-T-Cell Therapy

Who this might be right for
Hematologic Malignancies
Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06245915
What this trial is testing

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell CarcinomaRecurrence
Arsenal Biosciences, Inc. 37
Very early researchUnknownNCT03799913
What this trial is testing

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07523542
What this trial is testing

SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLupus Nephritis
Beijing Biotech 24
Testing effectiveness (Phase 2)Ended earlyNCT06342960
What this trial is testing

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 2
Early research (Phase 1)Looking for participantsNCT07172958
What this trial is testing

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Who this might be right for
RhabdomyosarcomaEwing SarcomaNeuroblastoma+1 more
Children's National Research Institute 18
Not applicableStudy completedNCT05130489
What this trial is testing

CAR T Cell Therapy Related Cardiovascular Outcomes

Who this might be right for
Cardiovascular DiseasesB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma Refractory+5 more
University College London Hospitals 150
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Early research (Phase 1)Looking for participantsNCT05483491
What this trial is testing

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Who this might be right for
Gastric CancerBreast CancerCervical Cancer+1 more
Christian Hinrichs 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07799116
What this trial is testing

Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis (LN)
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 10
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Next Page